Another Year, Another Setback: Scotiabank Economics' Global

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Another Year, Another Setback: Scotiabank Economics' Global Outlook

TORONTO, ON --(Marketwired - July 06, 2016) - The United Kingdom's decision to leave the European Union represents a major economic shock to the U.K. and Europe. It will lower business and household confidence in the U.K. and Europe, while also potentially fanning the flames of referenda in other countries given the electoral cycle in Europe. Despite the importance of the shock to Europe, it is expected that the impact beyond its borders will be relatively contained, as the United States, China and India remain on reasonably solid footing. On balance, our global growth forecast has been marked down from 3.1% to 3.0% in 2016, and from 3.5% to 3.3% in 2017.

"Scotiabank's global economics team offers perspectives on the global outlook from their respective positions on the ground to provide a fulsome view of the impact of Brexit and other factors that will influence the global economy into 2017," said Jean-François Perrault, Senior Vice President and Chief Economist at Scotiabank. "We see the most immediate impact of Brexit has been felt in financial markets, with some currencies and government bond yields adjusting rapidly to increased uncertainty and the potential economic consequences."

Highlights of Scotiabank's Global Outlook include:

  • United Kingdom: Minor recession predicted for the U.K. late this year, followed by no growth for 2017.
  • Europe: Eurozone growth forecast for 2017 cut half a percentage point to about 1%.
  • Canada: Little direct impacts from Brexit on Canada with growth expected at 1.3% this year and 2.0% in 2017 as the economy continues to adjust to the lower price of oil.
  • United States: Fundamentals of the U.S. economy remain solid despite weak trend growth.
  • Latin America: Prospects in Latin America remain mixed, given the importance of the U.S. economy to the region, and the expected improvement in many commodity prices, developments in the U.K. and Europe should not impose too much of a drag on the region.
  • Asia: Asian economies are also likely to be only modestly affected by Brexit in a direct manner. China's economic transition continues, with growth expected to slow to 6.2% in 2017.
  • Capital Markets: Yields are likely to remain extremely low for some time given the demand for safe assets, and the need for continued monetary policy support in most advanced economies. Yields on 10-year U.S. Treasuries expected to fall to 1.2%.
  • Currency: British Pound has more room to fall, to 1.25, as the U.K. navigates uncharted waters over the next quarters.
  • Commodities: Price of WTI is expected to rise to about $55/bbl in 2017, which will provide an additional boost to growth in Canada, but we continue to expect little new investment in the oil patch in 2017 given breakeven costs.

The economic impact of Brexit will be focused on the U.K. and Europe and should trigger a reduction in investment and household spending in both economies, with the impact expected to be more pronounced in the U.K. Despite these major revisions to prospects across the Atlantic, the real economic impacts on the rest of the world should be muted.

Watch a video of Jean-François Perrault discussing Scotiabank's Global Outlook here: https://youtu.be/0DndTCLJl8I

Read Scotiabank's Global Outlook online at: http://www.scotiabank.com/ca/en/0,,3112,00.html

Scotiabank provides clients with in-depth research into the factors shaping the outlook for Canada and the global economy, including macroeconomic developments, currency and capital market trends, commodity and industry performance, as well as monetary, fiscal and public policy issues.

About Scotiabank Scotiabank is Canada's international bank and a leading financial services provider in North America, Latin America, the Caribbean and Central America, and Asia-Pacific. We are dedicated to helping our 23 million customers become better off through a broad range of advice, products and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. With a team of more than 89,000 employees and assets of $895 billion (as at April 30, 2016), Scotiabank trades on the Toronto ( TSX : BNS ) and New York Exchanges ( NYSE : BNS ). Scotiabank distributes the Bank's media releases using Marketwired. For more information, please visit www.scotiabank.com and follow us on Twitter @ScotiabankViews.

Embedded Video Available: https://www.youtube.com/watch?v=0DndTCLJl8I&feature=youtu.be

For media enquiries only: Debra Chan Public, Corporate and Government Affairs Scotiabank (416) 866-6443 debra.chan@scotiabank.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 431

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Brixton Metals Delivers Promising Drill Results in Thorn Project

Updated Category News Views 167

Brixton Metals' Latest Drill Results Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) recently unveiled its second batch of drill results from the 2025 exploration season. The company operates the Thorn Project, an underexplored district known for its potential in copper-gold porphyry deposits. Highlighting Impressive Assay Results The recent drilling at the...

Continue Reading
US Labor Market Stagnation: A Closer Look at 2025 Trends

Updated Category News Views 275

November Layoffs and Hiring Trends In November, layoffs by U.S. employers reduced significantly, signaling a shift in the job market dynamics. Yet, companies are still hesitant to recruit new employees, indicating a labor market that remains restrained due to various pressures. Businesses are facing challenges such as soft demand, tariff implications, and soaring...

Continue Reading
Dollar Steady Amid Global Market Uncertainty and Yuan Weakness

Updated Category News Views 127

Asian Currency Markets React to U.S. Dollar Strength In the bustling arena of Asian currencies, the atmosphere is charged with anticipation as investors monitor the situation in China regarding potential economic stimulus measures. Meanwhile, the U.S. dollar is exhibiting remarkable strength, currently hovering near a two-and-a-half month high. This rise comes in light of...

Continue Reading
Understanding Recent Insider Trades at Omega Healthcare Invts

Updated Category News Views 75

Examining Insider Trades at Omega Healthcare Invts Recently, a notable insider trade involving Omega Healthcare Invts has drawn attention. Chief Operating Officer Daniel Booth executed a significant transaction, selling 56,725 shares as disclosed through an SEC filing. This particular sale took place on a recent date and revealed a total transaction value of $2,283,181....

Continue Reading
Exploring Future Growth in Healthcare Digital Payments Market

Updated Category News Views 150

Introduction to Digital Payments in Healthcare The transformation in the realm of healthcare is not just about treatments and services; it extends deeply into how payments are managed. The Digital Payment in Healthcare Market is evolving, with an anticipated growth in value reaching USD 61,521.8 Million by the year 2033. This incredible increase is projected to occur at a...

Continue Reading